Physician profile
Patrick J Geraghty
NPI 1376560821
$65,375.00
in general payments reported to CMS, 2019-2025
35 companies · $2,624 in 2025
The $2,624 reported for 2025 was more than what 75% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $1,391 · 2021: $36K · 2022: $3,041 · 2023: $4,741 · 2024: $1,963 · 2025: $2,624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,188 · Travel and Lodging: $2,140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,188.13 |
| Travel and Lodging | $2,139.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $42,301.16 | 2019-2022 | |
| Boston Scientific Corporation | $6,857.69 | 2019-2025 | General - Vascular Intervention |
| Medtronic, INC. | $3,169.23 | 2021-2025 | Turbohawk, Abre, Hawkone |
| W. L. Gore & Associates, INC. | $2,271.91 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Limflow INC. | $1,610.00 | 2023 | Limflow System |
| Elite Orthopedics, LLC | $1,200.00 | 2022 | |
| Inspiremd Ltd | $1,073.40 | 2023-2025 | Cguard Prime Carotid Stent System, Cguard |
| Penumbra, INC. | $969.39 | 2021-2025 | Penumbra System, Indigo System |
| Surmodics, INC. | $917.48 | 2021-2025 | Pounce Venous Thrombectomy System, Pounce Xl Thrombectomy, Pounce Thrombectomy |
| Philips North America LLC | $857.12 | 2019-2021 | |
| Intact Vascular, INC. | $769.77 | 2019 | |
| Inari Medical, INC. | $567.11 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cook Medical LLC | $456.33 | 2019-2025 | Zilver Ptx, Cook, Zenith Alpha |
| Silk Road Medical, INC. | $433.24 | 2020-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Veryan Medical Incorporated | $392.31 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $377.61 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $273.61 | 2019 | |
| Abbott Laboratories | $163.39 | 2024 | Esprit |
| Avantec Vascular Corporation | $122.46 | 2021 | |
| Bolton Medical INC | $88.59 | 2023-2024 | Treo Abdominal Stent-Graft System |
| Stryker Corporation | $78.68 | 2025 | Flowtriever |
| Endologix LLC | $68.84 | 2023 | |
| Asahi Intecc USA, INC. | $51.02 | 2021 | |
| Cardiovascular Systems INC. | $50.72 | 2021-2022 | |
| Neuros Medical, INC. | $49.15 | 2025 | Altius |
| Centerline Biomedical INC. | $48.33 | 2021 | |
| Cordis US Corp. | $36.40 | 2024 | Radial 360 |
| Shape Memory Medical INC. | $30.27 | 2024 | Impede Embolization Plug |
| Terumo Medical Corporation | $28.08 | 2020 | |
| Biotronik INC. | $18.59 | 2023 | Oscar |
| Medical Device Business Services, INC. | $18.54 | 2023 | Surgicel Nu-Knit |
| Tactile Systems Technology INC | $13.33 | 2019 | |
| Davol INC. | $11.25 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$51,554.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Geraghty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.